<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We did expressional profiling on 24 paired samples of <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">epithelium, Barrett</z:e>'s <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, and esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Matching tissue samples representing the three different histologic types were obtained from each patient undergoing esophagectomy for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Our analysis compared the molecular changes accompanying the transformation of <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in individual patients rather than in a random cohort </plain></SENT>
<SENT sid="3" pm="."><plain>We tested the hypothesis that expressional profiling may reveal gene sets that can be used as molecular markers of progression from <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Expressional profiling was done using U133A GeneChip (Affymetrix), which represent approximately two thirds of the human genome </plain></SENT>
<SENT sid="5" pm="."><plain>The final selection of 214 genes permitted the discrimination of differential gene expression of <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal squamous epithelium, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> using two-dimensional hierarchical clustering of selected genes </plain></SENT>
<SENT sid="6" pm="."><plain>These data indicate that transformation of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is associated with suppression of the genes involved in epidermal differentiation, including genes in 1q21 loci and corresponding to the epidermal differentiation complex </plain></SENT>
<SENT sid="7" pm="."><plain>Correlation analysis of genes concordantly expressed in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> revealed 21 genes that represent potential genetic markers of disease progression and pharmacologic targets for treatment intervention </plain></SENT>
<SENT sid="8" pm="."><plain>PCR analysis of genes selected based on DNA array experiments revealed that estimation of the ratios of GATA6 to SPRR3 allows discrimination among <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">epithelium, Barrett</z:e>'s <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>